XOMA Royalty (NASDAQ:XOMA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does XOMA Royalty (XOMA) operate in?

XOMA Royalty is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

XOMA Royalty Stock (NASDAQ: XOMA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 26.25K
Day Range	- - -
52 Wk Range	13.48 - 30.36
Market Cap	$315.08M
P/E Ratio	-
Dividend Yield	8.05%
Exchange	NASDAQ
RSI	45
Short Interest	3.05%
Days to Cover	11.39

Recent News

FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base

FDA's Genetic Metabolic Diseases Advisory Committee will review Zevra Therapeutics' arimoclomol for Niemann-Pick disease type C on August 2. PDUFA decision expected by September 21.

Vandana Singh

Lexicon Pharmaceuticals Reports Q1 Loss, Misses Revenue Estimates

Lexicon Pharmaceuticals (NASDAQ: LXRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma

XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Apr

May

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 26.25K
Day Range	- - -
52 Wk Range	13.48 - 30.36
Market Cap	$315.08M
P/E Ratio	-
Dividend Yield	8.05%
Exchange	NASDAQ
RSI	45
Short Interest	3.05%
Days to Cover	11.39

About XOMA Royalty Corp.

Sector

Health Care

Industry

Biotechnology

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy XOMA Royalty (XOMA) stock?

You can purchase shares of XOMA Royalty (NASDAQ:XOMA) through any online brokerage.

View our list of the best stock brokerages

Who are XOMA Royalty (XOMA) competitors?

Other companies in XOMA Royalty’s space includes: Inozyme Pharma (NASDAQ:INZY), Voyager Therapeutics (NASDAQ:VYGR), Zentalis Pharma (NASDAQ:ZNTL), Korro Bio (NASDAQ:KRRO) and Monte Rosa Therapeutics (NASDAQ:GLUE).

What is the forecast, or price target, for XOMA Royalty (XOMA) stock?

XOMA Royalty has a consensus price target of $78.50.

What is the current price for XOMA Royalty (XOMA)?

The stock price for XOMA Royalty (NASDAQ: XOMA) is $26.92 last updated September 24, 2024 at 4:01 PM EDT.

Does XOMA Royalty (XOMA) pay a dividend?

There are no upcoming dividends for XOMA Royalty.

When is XOMA Royalty (NASDAQ:XOMA) reporting earnings?

XOMA Royalty’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is XOMA Royalty (XOMA) going to split?

There is no upcoming split for XOMA Royalty.

What sector and industry does XOMA Royalty (XOMA) operate in?

XOMA Royalty is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge